Huadong Medicine Co Ltd
SZSE:000963
Relative Value
The Relative Value of one Huadong Medicine Co Ltd stock under the Base Case scenario is 60.51 CNY. Compared to the current market price of 32.94 CNY, Huadong Medicine Co Ltd is Undervalued by 46%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
Huadong Medicine Co Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
57.6B CNY | 1.4 | 21.3 | 15.5 | 15.5 | ||
US |
Mckesson Corp
NYSE:MCK
|
69.6B USD | 0.2 | 23.2 | 16.1 | 18.7 | ||
US |
Cencora Inc
NYSE:COR
|
45.7B USD | 0.2 | 24.5 | 12.5 | 17.6 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 0.1 | 20.9 | 11.3 | 15.2 | ||
US |
Cardinal Health Inc
NYSE:CAH
|
24.9B USD | 0.1 | 39 | 8.7 | 11.7 | ||
US |
Henry Schein Inc
NASDAQ:HSIC
|
8.9B USD | 0.7 | 21.4 | 11.3 | 15.2 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
60.5B HKD | 0.1 | 6.3 | 1.5 | 1.8 | ||
IT |
Amplifon SpA
MIL:AMP
|
7.2B EUR | 3.1 | 45.7 | 14.9 | 29.4 | ||
CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
51B CNY | 0.2 | 13.5 | 8 | 8 | |
DE |
M
|
McKesson Europe AG
XHAM:CLS1
|
5B EUR | 0.2 | -5.1 | 3.9 | 19.2 |